Reuters logo
BRIEF-Celgene Switzerland reports 10.8 pct stake in Jounce Therapeutics
February 10, 2017 / 9:17 PM / 9 months ago

BRIEF-Celgene Switzerland reports 10.8 pct stake in Jounce Therapeutics

Feb 10 (Reuters) - Celgene Switzerland LLC:

* Celgene Switzerland LLC reports passive stake of 10.8 percent in Jounce Therapeutics Inc as on February 1, 2017 - SEC filing Source text: (bit.ly/2kR99eh) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below